IMNM Immunome Inc.
Healthcare · Market cap: $2.1B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $1.2M | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $1.4M | $0 |
| 2024-Q3 | $97.6K | $279.3K |
| 2024-Q4 | $1.3M | $0 |
| 2025-Q1 | $2.4M | $0 |
| 2025-Q2 | $46.9K | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $1.5M | $8.3M |
| 2026-Q1 | $544.3K | $1.3M |
| 2026-Q2 | $307.8K | $6.2M |
| 2026-Q3 | $0 | $11.7M |
| 2026-Q4 | $0 | $0 |
Bought$8.8M25 buy days
Sold$27.8M23 sell days
Net insider flow-$19.0Mnet selling · 5 years
Latest trade2026-09-11Higgins Jack
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Sell | Higgins Jack | Other C-suite | 13,200 | $25.32 | $334.2K | 1 |
| 2026-08-12 | Sell | Barchas Isaac | Director | 11,048 | $27.25 | $301.1K | 1 |
| 2026-08-11 | Sell | Barchas Isaac | Director | 62,291 | $26.23 | $1.6M | 1 |
| 2026-08-10 | Sell | Barchas Isaac | Director | 10,125 | $26.07 | $264.0K | 1 |
| 2026-08-07 | Sell | Barchas Isaac | Director | 15,248 | $26.06 | $397.4K | 1 |
| 2026-08-06 | Sell | Barchas Isaac | Director | 20,840 | $26.06 | $543.1K | 1 |
| 2026-08-04 | Sell | Horn Kinney | Other C-suite | 90,616 | $25.09 | $2.3M | 1 |
| 2026-07-07 | Sell | Barchas Isaac | Director | 16,906 | $24.20 | $409.1K | 1 |
| 2026-07-07 | Sell | Horn Kinney | Other C-suite | 1,092 | $25.00 | $27.3K | 1 |
| 2026-07-06 | Sell | Barchas Isaac | Director | 83,094 | $24.11 | $2.0M | 1 |
| 2026-07-02 | Sell | Barchas Isaac | Director | 100,000 | $22.59 | $2.3M | 2 |
| 2026-07-02 | Sell | Lechleider Robert | Other C-suite | 55,000 | $22.62 | $1.2M | 3 |
| 2026-06-30 | Sell | Barchas Isaac | Director | 101,050 | $21.12 | $2.1M | 1 |
| 2026-06-25 | Sell | Lechleider Robert | Other C-suite | 55,000 | $19.85 | $1.1M | 2 |
| 2026-06-15 | Sell | Rosett Max | CFO | 60,000 | $18.23 | $1.1M | 1 |
| 2026-06-05 | Buy | BIENAIME JEAN JACQUES | Director | 10,500 | $19.45 | $204.3K | 3 |
| 2026-06-05 | Sell | BIENAIME JEAN JACQUES | Director | 10,500 | $19.41 | $203.8K | 2 |
| 2026-05-15 | Buy | BIENAIME JEAN JACQUES | Director | 5,000 | $20.70 | $103.5K | 1 |
| 2026-04-02 | Sell | Rosett Max | CFO | 65,000 | $21.92 | $1.4M | 2 |
| 2026-04-02 | Sell | Higgins Jack | Other C-suite | 9,438 | $21.64 | $204.2K | 1 |
| 2026-03-27 | Buy | SIEGALL CLAY B | CEO | 25,450 | $19.67 | $500.6K | 1 |
| 2026-03-23 | Sell | WAGENHEIM PHILIP | Director | 28,200 | $20.65 | $582.3K | 1 |
| 2026-03-20 | Sell | WAGENHEIM PHILIP | Director | 36,800 | $20.47 | $753.3K | 1 |
| 2026-03-11 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $21.55 | $21.6K | 1 |
| 2026-03-10 | Buy | BIENAIME JEAN JACQUES | Director | 1,000 | $22.12 | $22.1K | 1 |
| 2025-12-30 | Buy | SIEGALL CLAY B | CEO | 4,729 | $21.15 | $100.0K | 1 |
| 2025-12-22 | Sell | Barchas Isaac | Director | 383,200 | $21.74 | $8.3M | 2 |
| 2025-12-19 | Buy | Tsai Philip | Other C-suite | 10,000 | $20.49 | $204.9K | 1 |
| 2025-12-19 | Buy | SIEGALL CLAY B | CEO | 7,278 | $20.48 | $149.1K | 1 |
| 2025-12-18 | Buy | SIEGALL CLAY B | CEO | 46,511 | $21.50 | $1,000.0K | 1 |
| 2025-06-03 | Buy | BIENAIME JEAN JACQUES | Director | 5,000 | $9.38 | $46.9K | 1 |
| 2025-03-26 | Buy | SIEGALL CLAY B | CEO | 137,100 | $7.29 | $999.5K | 1 |
| 2025-03-25 | Buy | BIENAIME JEAN JACQUES | Director | 7,800 | $7.78 | $60.7K | 1 |
| 2025-03-24 | Buy | Tsai Philip | Other C-suite | 12,300 | $8.42 | $103.6K | 1 |
| 2025-03-24 | Buy | BIENAIME JEAN JACQUES | Director | 7,000 | $8.21 | $57.5K | 1 |
| 2025-01-31 | Buy | SIEGALL CLAY B | CEO | 150,000 | $7.75 | $1.2M | 1 |
| 2024-11-22 | Buy | SIEGALL CLAY B | CEO | 33,943 | $9.78 | $332.0K | 1 |
| 2024-11-21 | Buy | SIEGALL CLAY B | CEO | 66,057 | $9.54 | $630.2K | 1 |
| 2024-11-21 | Buy | Tsai Philip | Other C-suite | 21,000 | $9.43 | $198.0K | 1 |
| 2024-11-21 | Buy | Lechleider Robert | Other C-suite | 15,805 | $9.48 | $149.8K | 1 |
| 2024-09-19 | Sell | Rosett Max | CFO | 14,380 | $16.01 | $230.2K | 1 |
| 2024-08-16 | Buy | BIENAIME JEAN JACQUES | Director | 7,000 | $13.94 | $97.6K | 1 |
| 2024-08-15 | Sell | Higgins Jack | Other C-suite | 3,524 | $13.93 | $49.1K | 1 |
| 2024-05-21 | Buy | SIEGALL CLAY B | CEO | 20,434 | $13.78 | $281.6K | 1 |
| 2024-05-21 | Buy | BIENAIME JEAN JACQUES | Director | 2,000 | $13.57 | $27.1K | 1 |
| 2024-05-20 | Buy | SIEGALL CLAY B | CEO | 79,566 | $13.91 | $1.1M | 1 |
| 2023-10-02 | Buy | SIEGALL CLAY B | CEO | 169,204 | $5.91 | $1,000.0K | 1 |
| 2023-10-02 | Buy | Turner Bruce | Other C-suite | 42,300 | $5.91 | $250.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Barchas Isaac | Director | $0 | $18.3M | 2026-08-12 |
| SIEGALL CLAY B | CEO | $7.3M | $0 | 2026-03-27 |
| Rosett Max | CFO | $0 | $2.7M | 2026-06-15 |
| Lechleider Robert | Other C-suite | $149.8K | $2.3M | 2026-07-02 |
| Horn Kinney | Other C-suite | $0 | $2.3M | 2026-08-04 |
| WAGENHEIM PHILIP | Director | $0 | $1.3M | 2026-03-23 |
| BIENAIME JEAN JACQUES | Director | $641.2K | $203.8K | 2026-06-05 |
| Higgins Jack | Other C-suite | $0 | $587.6K | 2026-09-11 |
| Tsai Philip | Other C-suite | $506.5K | $0 | 2025-12-19 |
| Turner Bruce | Other C-suite | $250.0K | $0 | 2023-10-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-03-24 → 2025-03-26 | 3 | $1.2M | 62 | +18.0% (+12.9% raw) | +10.2% (+15.4% raw) | +34.3% (+52.5% raw) | closed |
| 2024-11-21 → 2024-11-22 | 3 | $1.3M | 63 | +6.3% (0.0% raw) | -4.5% (-15.3% raw) | -6.4% (-21.1% raw) | closed |
| 2021-05-24 → 2021-05-26 | 5 | $1.6M | 69 | -14.6% (-12.1% raw) | -30.6% (-32.6% raw) | -29.5% (-26.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.